Advertisement
HUM vs MOH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HUM is a Hold and MOH is a Hold.
Aroon Indicator for HUM shows an upward move is likely
HUM's Aroon Indicator triggered a bullish signal on September 18, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 239 similar instances where the Aroon Indicator showed a similar pattern. In 177 of the 239 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on HUM as a result. In 52 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for HUM just turned positive on October 05, 2026. Looking at past instances where HUM's MACD turned positive, the stock continued to rise in 33 of 50 cases over the following month. The odds of a continued upward trend are 66%.
HUM moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HUM crossed bullishly above the 50-day moving average on October 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.
Following a +11.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where HUM advanced for three days, in 219 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Bearish Trend Analysis
The 10-day RSI Indicator for HUM moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 24 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 65 cases where HUM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HUM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
HUM broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. HUM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.435) is normal, around the industry mean (3.247). P/E Ratio (36.827) is within average values for comparable stocks, (139.958). HUM's Projected Growth (PEG Ratio) (1.304) is slightly higher than the industry average of (0.786). Dividend Yield (0.009) settles around the average of (0.009) among similar stocks. P/S Ratio (0.319) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HUM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MOH's RSI Indicator climbs out of oversold territory
The RSI Oscillator for MOH moved out of oversold territory on October 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 24 of the 30 cases the stock moved higher. This puts the odds of a move higher at 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on MOH as a result. In 55 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for MOH just turned positive on October 06, 2026. Looking at past instances where MOH's MACD turned positive, the stock continued to rise in 33 of 46 cases over the following month. The odds of a continued upward trend are 72%.
MOH moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOH advanced for three days, in 214 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MOH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
MOH broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MOH entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating fairly steady price growth. MOH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.374) is normal, around the industry mean (3.247). MOH's P/E Ratio (1185.250) is considerably higher than the industry average of (139.958). Projected Growth (PEG Ratio) (0.880) is also within normal values, averaging (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.233) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MOH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
HUM | MOH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 79 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 90 | 100 | |
SMR RATING 1..100 | 98 | 90 | |
PRICE GROWTH RATING 1..100 | 6 | 44 | |
P/E GROWTH RATING 1..100 | 8 | 1 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HUM's Valuation (9) in the Managed Health Care industry is significantly better than the same rating for MOH (97). This means that HUM’s stock grew significantly faster than MOH’s over the last 12 months.
HUM's Profit vs Risk Rating (90) in the Managed Health Care industry is in the same range as MOH (100). This means that HUM’s stock grew similarly to MOH’s over the last 12 months.
MOH's SMR Rating (90) in the Managed Health Care industry is in the same range as HUM (98). This means that MOH’s stock grew similarly to HUM’s over the last 12 months.
HUM's Price Growth Rating (6) in the Managed Health Care industry is somewhat better than the same rating for MOH (44). This means that HUM’s stock grew somewhat faster than MOH’s over the last 12 months.
MOH's P/E Growth Rating (1) in the Managed Health Care industry is in the same range as HUM (8). This means that MOH’s stock grew similarly to HUM’s over the last 12 months.
| HUM | MOH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 75% | 2 days ago 80% |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 70% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 67% |
| MACD ODDS (%) | 2 days ago 66% | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 63% | 2 days ago 73% |
| TrendMonth ODDS (%) | 2 days ago 64% | 2 days ago 64% |
| Advances ODDS (%) | 4 days ago 63% | 3 days ago 67% |
| Declines ODDS (%) | 8 days ago 66% | 15 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 68% |
| Aroon ODDS (%) | 2 days ago 74% | 2 days ago 57% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HUM’s FA Score shows that 3 FA rating(s) are green while MOH’s FA Score has 1 green FA rating(s).
- HUM’s FA Score: 3 green, 2 red.
- MOH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HUM’s TA Score shows that 6 TA indicator(s) are bullish while MOH’s TA Score has 5 bullish TA indicator(s).
- HUM’s TA Score: 6 bullish, 4 bearish.
- MOH’s TA Score: 5 bullish, 4 bearish.
Price Growth
HUM (@Managed Health Care) experienced а +7.79% price change this week, while MOH (@Managed Health Care) price change was +7.38% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +4.83%. For the same industry, the average monthly price growth was +0.82%, and the average quarterly price growth was +49.53%.
Reported Earning Dates
HUM is expected to report earnings on Nov 06, 2026.
MOH is expected to report earnings on Oct 21, 2026.
Industries' Descriptions
@Managed Health Care (+4.83% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CORD | 4.62 | 1.08 | +30.51% |
| T-REX 2X Inverse CRWV Daily Target ETF (CORD) | |||
| BBN | 14.43 | 0.01 | +0.07% |
| BlackRock Taxable Municipal | |||
| HSCZ | 43.10 | -0.24 | -0.56% |
| iShares Currency Hedged MSCI EAFE Small-Cap ETF (HSCZ) | |||
| IVW | 141.82 | -2.74 | -1.90% |
| iShares S&P 500 Growth ETF (IVW) | |||
| LABX | 10.40 | -1.81 | -14.82% |
| Tradr 2X Long ALAB Daily ETF (LABX) | |||
HUM and
Correlation & Price change
A.I.dvisor indicates that over the last year, HUM has been closely correlated with UNH. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if HUM jumps, then UNH could also see price increases.